About William McKee
William McKee is a director at Assertio.
Form D filings name William McKee as a director at AI Proteins.
William McKee reports to the SEC as a director or officer of 8 public companies, including Rein Therapeutics (RNTX), C4 Therapeutics (CCCC) and Agile Therapeutics (AGRX).
William McKee first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name William McKee in the role, so the role may have started earlier or lasted longer.
AI
Assertio Holdings, Inc.
Director
2020 – 2026 · Public company (ASRT)
RI
Rein Therapeutics, Inc.
Director
2019 – 2022 · Public company (RNTX)
CI
C4 Therapeutics, Inc.
Chief Financial Officer
2020 · Public company (CCCC)
AI
Agile Therapeutics Inc.
Director
2014 – 2019 · Public company (AGRX)
AI
Assertio Therapeutics, Inc
Director
2017 – 2019 · Public company (ASRT)
DI
Dare Bioscience, Inc.
Director
2014 – 2017 · Public company (DARE)
AI
Auxilium Pharmaceuticals Inc.
Director
2009 – 2015 · Public company (AUXL)
BI
Barr Pharmaceuticals Inc.
EVP, CFO
2006 – 2008 · Public company (BRL)
Key Colleagues at Startups
The people William McKee works with at each company, as listed on that company's latest Form D.
AI Proteins, Inc. · Form D, Jan 21, 2022
DV
Dominique Verhelle
Director
JN
Julia Novina
Chief Legal Officer
MC
Marc Cohen
Executive officer and director
GM
Geoff Meyerson
Director
EP
Elena Prokupets
Director
CN
Carl Novina
Director
DD
Drew Dennison
Director
NB
Namandje Bumpus
Director
AB
Arthur Becker
Director
CB
Chris Bahl
Executive officer and director
MS
Malcolm Salter
Director